{"id":241782,"date":"2026-09-10T15:48:50","date_gmt":"2026-09-10T10:18:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=241782"},"modified":"2026-09-10T15:48:50","modified_gmt":"2026-09-10T10:18:50","slug":"why-piramal-pharma-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/","title":{"rendered":"Piramal Pharma (PPLPHARMA) Share Price Falls 2.71% Today to Rs 212.20"},"content":{"rendered":"
Piramal Pharma (PPLPHARMA)<\/a>share price fell to Rs 212.2 today, down 2.71% from the previous close. Market cap was Rs 30,168.35 crore.<\/em><\/div>\n

Piramal Pharma Share Price was at Rs 212.20 on 10 September 2026 at 3:23:03 PM IST, down 2.71% for the day. The stock had closed at Rs 218.10 in the previous session, so the decline amounted to Rs 5.90, while the company\u2019s market capitalisation stood at Rs 30,168.35 crore.<\/p>\n

For investors following Piramal Pharma Share Price Today, the confirmed data shows a clear same-day decline but does not identify any company-specific reason behind it. Even without a stated catalyst, the move remains relevant because Piramal Pharma is a large-cap name in the Healthcare sector and the Pharmaceuticals & Drugs industry, where valuation, profitability and peer comparison all influence how a stock is read on a weak day.<\/p>\n

The current snapshot also shows a mixed profile. The company\u2019s price-to-book ratio is 3.63, RSI is 58.42, 50-day DMA is 211.8 and 200-day DMA is 175.94. At the same time, profitability indicators remain soft, with ROE at -4.04, ROCE at 1.24 and EPS at -2.36. That combination makes the stock worth tracking not only for price action, but also for whether fundamentals begin to support valuation more convincingly.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n